| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BridgeBio Pharma, Inc. | Director | Common Stock | 916,674 | $44,000,352 | $48.00 | 11 Aug 2025 | Direct |
| Maze Therapeutics, Inc. | Director | Common Stock | 31,113 | $1,033,573 | $33.22 | 19 Nov 2025 | Direct |
| Maze Therapeutics, Inc. | Director | Common Stock | 7,422 | $246,558 | $33.22 | 19 Nov 2025 | By Trust |
| Maze Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 18,000 | 22 Sep 2025 | Direct | ||
| PLIANT THERAPEUTICS, INC. | Director | Stock Option (right to buy) | 13,286 | 29 Jun 2021 | Direct | ||
| BridgeBio Pharma, Inc. | Director | Stock Option (Right to Buy) | 8,425 | 20 Jun 2025 | Direct | ||
| Maze Therapeutics, Inc. | Director | Series D-1 Preferred Stock | 7,422 | 26 Nov 2024 | By Trust | ||
| Maze Therapeutics, Inc. | Director | Series B Preferred Stock | 0 | 03 Feb 2025 | Direct | ||
| Maze Therapeutics, Inc. | Director | Series C Preferred Stock | 0 | 03 Feb 2025 | Direct | ||
| Maze Therapeutics, Inc. | Director | 8% Convertible Note due 2026 | $0 | 26 Nov 2024 | By Trust |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MAZE | Maze Therapeutics, Inc. | 19 Nov 2025 | 1 | $0 | 4 | Director | 21 Nov 2025, 16:24 |
| MAZE | Maze Therapeutics, Inc. | 23 Oct 2025 | 1 | $0 | 4 | Director | 27 Oct 2025, 16:46 |
| MAZE | Maze Therapeutics, Inc. | 22 Sep 2025 | 1 | $0 | 4 | Director | 24 Sep 2025, 16:15 |
| BBIO | BridgeBio Pharma, Inc. | 08 Aug 2025 | 3 | -$13,912,443 | 4 | Director | 12 Aug 2025, 19:06 |
| BBIO | BridgeBio Pharma, Inc. | 27 Jun 2025 | 1 | $0 | 4 | Director | 30 Jun 2025, 17:54 |
| BBIO | BridgeBio Pharma, Inc. | 20 Jun 2025 | 2 | $0 | 4 | Director | 24 Jun 2025, 18:56 |
| MAZE | Maze Therapeutics, Inc. | 03 Feb 2025 | 15 | -$75,000 | 4 | Director | 04 Feb 2025, 16:35 |
| MAZE | Maze Therapeutics, Inc. | 30 Jan 2025 | 0 | $0 | 3 | Director | 30 Jan 2025, 16:31 |
| BBIO | BridgeBio Pharma, Inc. | 21 Jun 2024 | 1 | $0 | 4 | Director | 25 Jun 2024, 17:38 |
| BBIO | BridgeBio Pharma, Inc. | 16 Feb 2024 | 3 | -$56,150 | 4 | Director | 21 Feb 2024, 16:04 |
| BBIO | BridgeBio Pharma, Inc. | 16 Nov 2023 | 3 | -$37,547 | 4 | Director | 20 Nov 2023, 16:00 |
| BBIO | BridgeBio Pharma, Inc. | 16 Aug 2023 | 3 | -$38,770 | 4 | Director | 18 Aug 2023, 17:00 |
| BBIO | BridgeBio Pharma, Inc. | 21 Jun 2023 | 1 | $0 | 4 | Director | 23 Jun 2023, 16:20 |
| BBIO | BridgeBio Pharma, Inc. | 16 May 2023 | 3 | -$18,317 | 4 | Director | 18 May 2023, 16:05 |
| BBIO | BridgeBio Pharma, Inc. | 16 Feb 2023 | 3 | -$19,390 | 4 | Director | 21 Feb 2023, 19:18 |
| BBIO | BridgeBio Pharma, Inc. | 16 Nov 2022 | 3 | -$12,542 | 4 | Director | 18 Nov 2022, 17:36 |
| BBIO | BridgeBio Pharma, Inc. | 16 Aug 2022 | 3 | -$14,260 | 4 | Director | 18 Aug 2022, 18:33 |
| BBIO | BridgeBio Pharma, Inc. | 22 Jun 2022 | 1 | $0 | 4 | Director | 24 Jun 2022, 16:30 |
| BBIO | BridgeBio Pharma, Inc. | 16 May 2022 | 3 | -$10,386 | 4 | Director | 18 May 2022, 16:05 |
| BBIO | BridgeBio Pharma, Inc. | 28 Feb 2022 | 1 | $0 | 4 | Director | 15 Mar 2022, 17:34 |
| BBIO | BridgeBio Pharma, Inc. | 02 Dec 2021 | 1 | $0 | 4 | Director | 06 Dec 2021, 19:58 |
| PLRX | PLIANT THERAPEUTICS, INC. | 29 Jun 2021 | 1 | $0 | 4 | Director | 30 Jun 2021, 20:37 |
| BBIO | BridgeBio Pharma, Inc. | 17 Jun 2021 | 1 | $0 | 4 | Director | 22 Jun 2021, 19:16 |